1. Home
  2. TELO

as 05-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Founded: 2021 Country:
United States
United States
Employees: N/A City: TAMPA
Market Cap: 186.5M IPO Year: 2024
Target Price: N/A AVG Volume (30 days): 44.7K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.64 EPS Growth: N/A
52 Week Low/High: $4.76 - $20.72 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of TELOMIR PHARMACEUTICALS INC (TELO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Bay Shore Trust TELO 10% Owner Feb 13 '24 Buy $7.00 49,000 $343,000.00 5,455,431 SEC Form 4
Bay Shore Trust TELO 10% Owner Feb 13 '24 Buy $7.00 40,000 $280,000.00 1,365,646 SEC Form 4
Bay Shore Trust TELO 10% Owner Feb 13 '24 Buy $7.00 49,000 $343,000.00 1,902,659 SEC Form 4

Latest TELOMIR PHARMACEUTICALS INC News

TELO Breaking Stock News: Dive into TELO Ticker-Specific Updates for Smart Investing

All TELO News